Inhibition of Cytochrome P450 by Propolis in Human Liver Microsomes

Although propolis is one of the most popular functional foods for human health, there have been no comprehensive studies of herb-drug interactions through cytochrome P450 (CYP) inhibition. The purpose of this study was to determine the inhibitory effects of propolis on the activities of CYP1A2, 2A6, 2B6, 2C9, 2C19, 2D6, 2E1 and 3A4 using pooled human liver microsomes (HLMs). Propolis inhibited CYP1A2, CYP2E1 and CYP2C19 with an IC50 value of 6.9, 16.8, and 43.1 μg/mL, respectively, whereas CYP2A6, 2B6, 2C9, 2D6, and 3A4 were unaffected. Based on half-maximal inhibitory concentration shifts between microsomes incubated with and without nicotinamide adenine dinucleotide phosphate, propolis-induced CYP1A2, CYP2C19, and CYP2E1 inhibition was metabolism-independent. To evaluate the interaction potential between propolis and therapeutic drugs, the effects of propolis on metabolism of duloxetine, a serotonin-norepinephrine reuptake inhibitor, were determined in HLMs. CYP1A2 and CYP2D6 are involved in hydroxylation of duloxetine to 4-hydroxy duloxetine, the major metabolite, which was decreased following propolis addition in HLMs. These results raise the possibility of interactions between propolis and therapeutic drugs metabolized by CYP1A2.

[1]  Hyung Gyun Kim,et al.  Caffeic acid phenethyl ester inhibits 3-MC-induced CYP1A1 expression through induction of hypoxia-inducible factor-1α. , 2015, Biochemical and biophysical research communications.

[2]  Masashi Kato,et al.  Effects of an ethanol extract of Brazilian green propolis on human cytochrome P450 enzyme activities in vitro. , 2014, Journal of agricultural and food chemistry.

[3]  S. Oh,et al.  Inhibition of cytochrome P450 by ethambutol in human liver microsomes. , 2014, Toxicology letters.

[4]  K. Kwon,et al.  Quantitative determination of duloxetine and its metabolite in rat plasma by HPLC-MS/MS. , 2013, Biomedical chromatography : BMC.

[5]  K. Lee,et al.  Direct and metabolism‐dependent cytochrome P450 inhibition assays for evaluating drug–drug interactions , 2013, Journal of applied toxicology : JAT.

[6]  S. Oh,et al.  In vitro and in vivo assessment of cytochrome P450-mediated herb-drug interaction of Ssang-hwa-tang. , 2013, Food chemistry.

[7]  Soo Jin Oh,et al.  Cytochrome P450-mediated herb-drug interaction potential of Galgeun-tang. , 2013, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[8]  S. Oh,et al.  Assessment of drug-drug interactions caused by metabolism-dependent cytochrome P450 inhibition. , 2012, Chemico-biological interactions.

[9]  A. Sierra-Santoyo,et al.  Cancer Prevention Mediated by Caffeic Acid Phenethyl Ester Involves Cyp2b1/2 Modulation in Hepatocarcinogenesis , 2012, Toxicologic pathology.

[10]  Kwang-Hyeon Liu,et al.  Evaluation of metabolism-mediated herb-drug interactions , 2011, Archives of pharmacal research.

[11]  C. Chaiyasut,et al.  Inhibitory effects of caffeic acid ester analogues on free radicals and human liver microsome CYP1A2 activities. , 2011, Medicinal chemistry (Shariqah (United Arab Emirates)).

[12]  Y. Imamura,et al.  Differential mechanisms for the inhibition of human cytochrome P450 1A2 by apigenin and genistein , 2010, Journal of biochemical and molecular toxicology.

[13]  Hideyuki Ito,et al.  Inhibitory effects of polyphenols on human cytochrome P450 3A4 and 2C9 activity. , 2010, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[14]  M. Scippo,et al.  CYP1A1 and CYP3A4 modulation by dietary flavonoids in human intestinal Caco-2 cells. , 2009, Toxicology letters.

[15]  Rui Wang,et al.  Potential cytoprotection: antioxidant defence by caffeic acid phenethyl ester against free radical-induced damage of lipids, DNA, and proteins. , 2008, Canadian journal of physiology and pharmacology.

[16]  P. Ruzza,et al.  Flavonoids diosmetin and luteolin inhibit midazolam metabolism by human liver microsomes and recombinant CYP 3A4 and CYP3A5 enzymes. , 2008, Biochemical pharmacology.

[17]  R. Foti,et al.  CYP2C19 Inhibition: The Impact of Substrate Probe Selection on in Vitro Inhibition Profiles , 2008, Drug Metabolism and Disposition.

[18]  B. Ring,et al.  In Vitro and In Vivo Evaluations of Cytochrome P450 1A2 Interactions with Duloxetine , 2008, Clinical pharmacokinetics.

[19]  S. Shukla,et al.  Propolis protects CYP 2E1 enzymatic activity and oxidative stress induced by carbon tetrachloride , 2007, Molecular and Cellular Biochemistry.

[20]  S. Kumazawa,et al.  Antioxidant activity and constituents of propolis collected in various areas of China , 2007 .

[21]  S. Strom,et al.  In vitro and in vivo assessment of herb drug interactions. , 2006, Life sciences.

[22]  G. Rusak,et al.  Oxidant/antioxidant properties of Croatian native propolis. , 2006, Journal of agricultural and food chemistry.

[23]  U. Fuhr,et al.  Assessment of CYP1A2 activity in clinical practice: why, how, and when? , 2005, Basic & clinical pharmacology & toxicology.

[24]  S. Silici,et al.  Chemical composition and antibacterial activity of propolis collected by three different races of honeybees in the same region. , 2005, Journal of ethnopharmacology.

[25]  T. Gillespie,et al.  Metabolism, excretion, and pharmacokinetics of duloxetine in healthy human subjects. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[26]  Sung-jin Kim,et al.  The protective effects of Propolis on hepatic injury and its mechanism , 2003, Phytotherapy research : PTR.

[27]  L. Bertilsson,et al.  Low daily 10‐mg and 20‐mg doses of fluvoxamine inhibit the metabolism of both caffeine (cytochrome P4501A2) and omeprazole (cytochrome P4502C19) , 2002, Clinical pharmacology and therapeutics.

[28]  C. Yoon,et al.  Structure-related inhibition of human hepatic caffeine N3-demethylation by naturally occurring flavonoids. , 1998, Biochemical pharmacology.

[29]  M Vuelta,et al.  [Food-drug interactions]. , 1997, Enfermeria intensiva.

[30]  D. Koop,et al.  Formation of 19(S)-, 19(R)-, and 18(R)-hydroxyeicosatetraenoic acids by alcohol-inducible cytochrome P450 2E1. , 1993, The Journal of biological chemistry.

[31]  U. Fuhr,et al.  Inhibitory potency of quinolone antibacterial agents against cytochrome P450IA2 activity in vivo and in vitro , 1992, Antimicrobial Agents and Chemotherapy.